Quantcast

Latest schizophrenia Stories

2014-03-03 08:31:55

ADASUVE is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults MOUNTAIN VIEW, Calif., March 3, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE(®) (loxapine) inhalation powder 10mg by its commercial partner, Teva Pharmaceutical Industries Ltd., (NYSE: TEVA). ADASUVE is the first and only orally inhaled medicine for the acute...

2014-03-03 08:30:51

NEW YORK, March 3, 2014 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (NASDAQ: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease....

2014-02-26 16:28:49

NEW YORK, Feb. 26, 2014 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) today announced Dr. Sharon Mates, Ph.D., President and Chief Executive Officer, will present at the Cowen and Company 34(th) Annual Healthcare Conference on March 3, 2014 at 2:50 p.m. Eastern Time in Boston, MA. Dr. Mates will provide a corporate overview and business update. The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the...

2014-02-24 09:12:45

Columbia University Medical Center Potential target for treating autism, schizophrenia, and other brain disorders NEW YORK, NY (February 23, 2014) — Columbia University Medical Center (CUMC) researchers have determined that a small region of the hippocampus known as CA2 is essential for social memory, the ability of an animal to recognize another of the same species. A better grasp of the function of CA2 could prove useful in understanding and treating disorders characterized by...

Understanding Autism And Schizophrenia
2014-02-24 08:21:53

Mathilde Weirsøe, Aarhus University In a study to be published in Psychological Science, researchers from Aarhus University and the University of Copenhagen demonstrate that brain cells in what is called the mirror system help people make sense of the actions they see other people perform in everyday life. Using magnetic stimulation to temporarily disrupt normal processing of the areas of the human brain involved in the production of actions of human participants, it is demonstrated...

2014-02-21 23:03:33

Drug Allgedly Linked to Breast Enlargement in Males DALLAS (PRWEB) February 21, 2014 The national plaintiffs’ law firm of Baron and Budd announces that it is now handling lawsuits relative to the drug Risperdal. Risperdal is prescribed to treat children, adolescents and adults with schizophrenia. Baron and Budd lawyers are working with males who allegedly suffered breast enlargement after taking the drug. Risperdal, manufactured by Johnson & Johnson, was first approved by the Food...

2014-02-19 08:32:36

LONDON, Feb. 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022 EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022 Summary Schizophrenia is a chronic, severe, and disabling group of psychotic disorders characterized by fundamental disturbances of thinking such as hallucinations, delusions, disorganized communication, and reduced motivation. Schizophrenia affects men and...

2014-02-19 08:30:37

-- PDE10 Inhibitor Administered to Patients with Huntington's Disease -- SEATTLE, Feb. 19, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance...

2014-02-12 23:27:42

The Brain & Behavior Research Foundation names 10 recent discoveries funded by its NARSAD Grants. (PRWEB) February 12, 2014 The Brain & Behavior Research Foundation Names 10 Recent Discoveries Funded by its NARSAD Grants That Will Help Understand, Treat and Cure Mental Illnesses The Brain & Behavior Research Foundation has named 10 recent discoveries, funded by its NARSAD Grants, that provide new insight into the mysteries of the brain and potential treatments for people with...

2014-02-11 16:25:38

First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versacloz(TM) (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder. "We are pleased to offer patients with...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related